Author: Publisher:
ISBN:
Category :
Languages : en
Pages : 1236
Book Description
House documents
Author: Reports of Committees
Author: United States. Congress. HousePublisher:
ISBN:
Category : United States
Languages : en
Pages : 1274
Book Description
Congressional Record
Author: United States. CongressPublisher:
ISBN:
Category : Law
Languages : en
Pages : 1016
Book Description
Prominent Families of New York
Author: Lyman Horace WeeksPublisher:
ISBN:
Category : New York (N.Y.)
Languages : en
Pages : 64
Book Description
Style Manual of the Government Printing Office
Author: Style Manual of Government Printing Office
Author: Parliamentary Precedents of the House of Representatives of the United States
Author: Asher Crosby HindsPublisher:
ISBN:
Category : Parliamentary practice
Languages : en
Pages : 1204
Book Description
The Encyclopedia of the United States Congress
Author: Donald C. BaconSenate and House Journals
Author: Kansas. Legislature. SenatePublisher:
ISBN:
Category : Kansas
Languages : en
Pages : 784
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.